Advances in CLL treatment
14 Jul 2011
Advances in CLL treatment
TKI treatment for chronic myeloid leukaemia
Communicating end of life options
Advances in the treatment of multiple myeloma
ASCO 2011 highlights
Second generation TKIs in chronic myeloid leukaemia
Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma
Role of maintenance therapy in multiple myeloma
Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology
Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy
New findings in proteasome inhibitors for myeloma patients
Reducing global cancer mortality